American Society of Health-System Pharmacists, 2018 - Present

American Society for Microbiology, 2012 – Present 

Society of Infectious Diseases Pharmacists, 2011 - Present 

Making a Difference in Infectious Diseases Pharmacotherapy, 2011 - Present 

American College of Clinical Pharmacy, 2009 - Present

OSU ID Fellowship Program Teacher of the Year Award, 2022

OSU College of Pharmacy Preceptor of the Year, 2022

Staff Career Development Grant Recipient, 2018

OSUWMC Residency Research Impact Award, 2018

University of Kentucky College of Pharmacy Statewide Preceptor of the Year, 2016

University of Louisville Hospital PGY1 Residency Program Preceptor of the Year, 2014

Caputo R, Rozycki A, McClain M, Sobhanie MM, Coe K, Colburn N, Wardlow L. Clinical outcomes with ertapenem for pneumonia in obese versus nonobese patients. Antimicrob Agents Chemother. 2022;66(1):e01325-21.

Lorenz A, Sobhanie MME, Orzel L, Coe K, Wardlow L. Clinical outcomes of combination versus monotherapy for gram negative non-HACEK infective endocarditis. Diag Microbiol Infect Dis. 2021;101(3):115504.

Tossey JC, El Boghdadly Z, Reed EE, Dela-Pena J, Coe K, Williams SN, Wardlow LC. Oral fluoroquinolones for definitive treatment of gram-negative bacteremia in cancer patients. Support Care Cancer. 2021;29(9):5057-5064.

Agnello S, Wardlow LC, Reed E, Smith JM, Coe K, Day SR. Clinical outcomes of daptomycin versus anti-staphylococcal beta-lactams in definitive treatment of methicillin-susceptible Staphylococcus aureus bloodstream infections. Inter J Antimicrob Agents. 2021;58(2):106363.

Taylor AP, Coe K, Stevenson K, Wardlow L, Boghdadly ZE, Reed E. Clinical impact of an antibiotic time out initiative at an academic medical center. Hosp Pharm. 2021;56(4):343-346.

Nichols CN, Wardlow LC, Coe KE, Sobhanie MME. Clinical outcomes with definitive treatment of methicillin-resistant Staphylococcus aureus bacteremia with retained daptomycin and ceftaroline combination therapy vs de-escalation to monotherapy with vancomycin, daptomycin, or ceftaroline. Op Forum Infect Dis. 2021;8(7):ofab327.

Vlashyn OO, Lorenz A, Sobhanie MM, Smith JM, Bond M, Wardlow L. Safety outcomes with high-dose daptomycin in patients with acute kidney injury and/or end-stage renal disease. J Clin Phar Ther. 2021;46(2):363-368.

Holsen MR, Wardlow LC, Bazan JA, Fussner LA, Coe KE, Elefritz JL. Clinical outcomes following treatment of Enterobacter species pneumonia with piperacillin/tazobactam compared to cefepime or ertapenem. Inter J Antimicrob Agents. 2019;54(6):824-828.

Shah MD, Coe KE, El Boghdadly Z, Wardlow LC, Dela-Pena JC, Stevenson KB, Reed EE. Efficacy of combination therapy versus monotherapy in the treatment of Stenotrophomonas maltophilia pneumonia. J Antimicrob Chemother. 2019;74(7):2055-2059. 

Shah MD, Wardlow LC, Stevenson KB, Coe KE, Reed EE. Clinical outcomes with penicillin versus alternative B-lactams in the treatment of penicillin susceptible Staphylococcus aureus bacteremia. Pharmacotherapy. 2018 May 25. doi: 10.1002/phar.2124

Arnold FW, Heishman C, Wardlow LC, Hummel L, Munier G, Snyder JW. A case of a metallo-B-lactamase producing Klebsiella pneumoniae in Louisville, Kentucky: how to prevent the next hospital outbreak of carbapenem-resistant Enterobacteriaceae. J Ky Med Assoc. 2014;112(2):23-29.

Phan H, Wardlow LC. Pediatric Immunizations. In: Katz MD, Matthias K, Chisholm-Burns M (eds). Pharmacotherapy Principles & Practice Study Guide: A Case-based Care Plan Approach. 2nd- 4th ed. New York: McGraw-Hill, 2011, 2013, 2016.